The history of Viagra presents a complex picture for shareholders. While the initial launch generated significant gains, the end of its intellectual property protection opened the avenue to cheaper alternatives, dramatically eroding market share. This presents a specific dilemma for firms depending on similar blockbuster medications, suggesting tha

The history of Viagra, and its developer copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in sales , its exclusivity period created a wave of knock-off medications, significantly impacting its market share . While specific businesses may attempt to capitalize on related treatments , the cur